Journal of Oncological Sciences
Turkish Society of Oncology
Journal websitePeer review: Double-blind review
Evaluation status available after sign-in
About the journal
Journal of Oncological Sciences is an open-access journal published by Turkish Society of Oncology in Türkiye, publishing in english. It is listed in DOAJ according to the sources read. Declared review time at DOAJ: 18 weeks. Facts are reproduced as recorded at their sources with their capture dates; PublishLens indicators are available after sign-in.
Basic facts
- Publisher
- Turkish Society of Oncology
- ISSN
- 2452-3364
- Country
- Türkiye
- Languages
- english
- Access
- Open access
- Articles in DOAJ
- 217
- Declared review time
- 18 weeks
- Declared peer-review model
- double_blind
- Official website
- https://www.journalofoncology.org/policies#open-access-policy
Index listings
- DOAJ · 2017-08-29
- Indexing
- DOAJ
- APC
- —
- Declared review time (DOAJ)
- 18 weeks — journal-declared only (not measured)
- Activity (OpenAlex)
- Active — latest works 2026
- PublishLens list status
- Shown after sign-in
- Counts for promotion at your university?
- Choose your university and rank below ↓
Methodology signals (dated facts from their sources)
Details of the evaluation under the published methodology are shown to signed-in users (free).
Create a free account to view the evaluationJournal profile
Descriptive metadata from public sources (DOAJ, OpenAlex, PubMed) as of the capture date shown — contains no assessment or judgment.
Articles in DOAJ
217
Most recent article
last month
Average review time (journal-declared via DOAJ)
18weeks
Works in OpenAlex
332
Last recorded publication year
2026
Reported by OpenAlex in 2 of 3 sources (CC0 flags, not verified indexing)DOAJSciELOOpenAlex Core
h-index
16
i10-index
26
From OpenAlex open data (CC0).
Editorial & policy11
- Last DOAJ review date
- 2025-10-21
- Added to DOAJ
- 2017-08-29
- Declared plagiarism screening
- Declared
- Other fees beyond APC
- No
- Declared digital preservation
- Internet Archive
- Observed digital preservation (Keepers registry)— snapshot 2026-10-05
- CLOCKSSPortico
- Editorial board
- Official page ↗
- Open references deposited at Crossref
- 78%
- ORCID iDs in current deposits
- 0%
- Enrolled in Crossref Similarity Check
- ✓
- Peer-review policy
- View policy
Identity & continuity2
- Alternate titles
- Journal of oncological sciencesJOS
- Source type
- journal
Classification2
Subjects (DOAJ)
Medicine: Internal medicine: Neoplasms. Tumors. Oncology. Including cancer and carcinogens
LCC codes
RC254-282
Subject areas
- Breast Cancer Treatment Studies
- Lung Cancer Treatments and Mutations
- Lung Cancer Treatments and Mutations
- Inflammatory Biomarkers in Disease Prognosis
- Gastric Cancer Management and Outcomes
- Cancer Immunotherapy and Biomarkers
- Gastric Cancer Management and Outcomes
- Lung Cancer Diagnosis and Treatment
Show all subjects (75)
- Colorectal Cancer Treatments and Studies
- Gastric Cancer Management and Outcomes
- Colorectal Cancer Treatments and Studies
- Breast Lesions and Carcinomas
- Colorectal Cancer Treatments and Studies
- Lung Cancer Treatments and Mutations
- Breast Cancer Treatment Studies
- Breast Cancer Treatment Studies
- Cancer survivorship and care
- Cancer Diagnosis and Treatment
- Metastasis and carcinoma case studies
- Lung Cancer Research Studies
- Cancer Diagnosis and Treatment
- Lung Cancer Research Studies
- Cancer Immunotherapy and Biomarkers
- Cancer Treatment and Pharmacology
- Cancer Immunotherapy and Biomarkers
- Cancer Treatment and Pharmacology
- Lung Cancer Research Studies
- Pancreatic and Hepatic Oncology Research
- Intraperitoneal and Appendiceal Malignancies
- HER2/EGFR in Cancer Research
- HER2/EGFR in Cancer Research
- Pancreatic and Hepatic Oncology Research
- Pancreatic and Hepatic Oncology Research
- Colorectal Cancer Surgical Treatments
- Advanced Breast Cancer Therapies
- Advanced Breast Cancer Therapies
- Cancer Treatment and Pharmacology
- Inflammatory Biomarkers in Disease Prognosis
- Head and Neck Cancer Studies
- Sarcoma Diagnosis and Treatment
- Cancer Genomics and Diagnostics
- Colorectal and Anal Carcinomas
- Gastrointestinal Tumor Research and Treatment
- Cancer Genomics and Diagnostics
- Colorectal and Anal Carcinomas
- Gastrointestinal Tumor Research and Treatment
- Ovarian cancer diagnosis and treatment
- Renal cell carcinoma treatment
- Inflammatory Biomarkers in Disease Prognosis
- Metastasis and carcinoma case studies
- Metastasis and carcinoma case studies
- Renal cell carcinoma treatment
- HER2/EGFR in Cancer Research
- Renal cell carcinoma treatment
- Glioma Diagnosis and Treatment
- Pancreatitis Pathology and Treatment
- COVID-19 and healthcare impacts
- COVID-19 and healthcare impacts
- Brain Metastases and Treatment
- Brain Metastases and Treatment
- COVID-19 and healthcare impacts
- Esophageal Cancer Research and Treatment
- Prostate Cancer Treatment and Research
- Lung Cancer Diagnosis and Treatment
- Sarcoma Diagnosis and Treatment
- Multiple and Secondary Primary Cancers
- Neuroendocrine Tumor Research Advances
- Ovarian cancer diagnosis and treatment
- Ovarian cancer diagnosis and treatment
- Prostate Cancer Treatment and Research
- Sarcoma Diagnosis and Treatment
- Neuroendocrine Tumor Research Advances
- Lung Cancer Diagnosis and Treatment
- Glioma Diagnosis and Treatment
- Glioma Diagnosis and Treatment
Keywords (DOAJ)
- oncology
- medicine
- health sciences
- cancer
Community confirmations — what users saw in MJL or Scopus Sources; not platform verification and never part of any score.
Loading community confirmations…
The journal's record in other sources:Web of Science MJLDOAJ